2Badsha H, Kong KO, Lian TY, et al. Low-dose pulse methylprednisolone for systemic lupus Erythematosus flares is efficacious and has a decreased risk of infectious complications[J]. Lupus,2002, 11:508 -513.
3Boumpas DT, Austin HA, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis[ J]. Lancet, 1992 ; 340: 741 -745.
4Abu-Shakra M, Shoenfeld Y. Azathioprine therapy for patients with systemic lupus erythematosus[ J]. Lupus, 2001, 10:152 -153.
5American college of rheumatology Ad Hoc committee on systemic lupus erythrmatesus guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults[J]. Arthritis Rheum, 1999, 42:1785 -1796.
6Boumpas DT, Austin HA, Vaughan EM, et al. Risk for sustained amenorrhea in patients with sustemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy [ J ]. Ann Intern Med, 1993, 119 : 366 - 369.
7Takada K, IUei GG, Boumpas DT. Cyclophosphamide for the treatment of systemic lupus erythematosus[ J ]. Lupus, 2001, 10: 154-161.
8Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis[ J ]. Ann Imtern Med, 2001, 135:248 -257.
9Houssiau FA, Vasconcelos C, D' Cruz D, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low- dose versus high- dose intravenous cyclophosphamide [ J ]. Arthritis Rheum, 2002, 46:2121 -2131.
10Stojanovich L, Stojanovich R, Kostich V, et al. Neuropsychiatric lupus favourable response to low dose i. v. cyclophosphamide and predniselone(pilot study) [J]. Lupus, 2003, 12:3 -7.
